Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Stealth BioTherapeutics stock
Learn how to easily invest in Stealth BioTherapeutics stock.
Stealth BioTherapeutics Corp is a biotechnology business based in the US. Stealth BioTherapeutics shares (MITO) are listed on the NASDAQ and all prices are listed in US Dollars. Stealth BioTherapeutics employs 38 staff and has a trailing 12-month revenue of around $21.1 million.
How to buy shares in Stealth BioTherapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – MITO – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Stealth BioTherapeutics stock price (NASDAQ: MITO)Use our graph to track the performance of MITO stocks over time.
Stealth BioTherapeutics shares at a glance
|Latest market close||$0.31|
|52-week range||$0.16 - $1.50|
|50-day moving average||$0.29|
|200-day moving average||$0.47|
|Wall St. target price||$1.77|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.92|
Buy Stealth BioTherapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Stealth BioTherapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Stealth BioTherapeutics price performance over time
|1 week (2022-09-23)||-0.51%|
|1 month (2022-09-01)||-1.58%|
|3 months (2022-07-01)||26.90%|
|6 months (2022-03-28)||N/A|
|1 year (2021-10-01)||-76.62%|
|2 years (2020-10-01)||-76.45%|
|3 years (2019-10-01)||6.46|
|5 years (2017-09-27)||N/A|
Stealth BioTherapeutics financials
|Revenue TTM||$21.1 million|
|Gross profit TTM||$21.1 million|
|Return on assets TTM||-67.24%|
|Return on equity TTM||-1666.63%|
|Market capitalisation||$23 million|
TTM: trailing 12 months
Stealth BioTherapeutics share dividends
We're not expecting Stealth BioTherapeutics to pay a dividend over the next 12 months.
Stealth BioTherapeutics share price volatility
Over the last 12 months, Stealth BioTherapeutics's shares have ranged in value from as little as $0.162 up to $1.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Stealth BioTherapeutics's is 1.6325. This would suggest that Stealth BioTherapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Stealth BioTherapeutics overview
Stealth BioTherapeutics Corp, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. Its lead product candidate is Elamipretide that is in phase 3 clinical trial to treat barth syndrome, phase 2/3 clinical trial for the treatment of duchenne cardiomyopathy, phase 2a clinical trial to treat friedreich's ataxia, phase 2 clinical trial for the treatment of dry age-related macular degeneration, phase 2 clinical trial to treat leber's hereditary optic neuropathy, and phase 3 clinical trial for the treatment of replisome myopathies. The company's product candidates also include SBT-20 to treat complications of diabetes, renal diseases, ocular diseases, neurodegenerative, Parkinson's, Alzheimer's, Huntington's, and ALS diseases; SBT-550 for rare neurological indications; and SBT-272, a peptidomimetic that targets the mitochondria and stabilizing mitochondrial function under conditions of oxidative stress, as well as SBT 550. Stealth BioTherapeutics Corp was incorporated in 2006 and is based in George Town, the Cayman Islands. .
Frequently asked questionsWhat percentage of Stealth BioTherapeutics is owned by insiders or institutions?
Currently 0.157% of Stealth BioTherapeutics shares are held by insiders and 8.439% by institutions. How many people work for Stealth BioTherapeutics?
Latest data suggests 38 work at Stealth BioTherapeutics. When does the fiscal year end for Stealth BioTherapeutics?
Stealth BioTherapeutics's fiscal year ends in December. Where is Stealth BioTherapeutics based?
Stealth BioTherapeutics's address is: 190 Elgin Avenue, George Town, Cayman Islands, KY1-9005 What is Stealth BioTherapeutics's ISIN number?
Stealth BioTherapeutics's international securities identification number is: US85789A1051 What is Stealth BioTherapeutics's CUSIP number?
Stealth BioTherapeutics's Committee on Uniform Securities Identification Procedures number is: 85789A105
More guides on Finder
Alternatives to Webull
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
Best renewable energy stocks for 2022
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
The best dividend stocks for 2022
Our list of 10 dividend stocks to watch in 2022.
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Ask an Expert